TBH Global Asset Management LLC Trims Position in HCA Healthcare, Inc. (NYSE:HCA)

TBH Global Asset Management LLC reduced its stake in HCA Healthcare, Inc. (NYSE:HCAFree Report) by 13.1% during the 4th quarter, according to the company in its most recent filing with the Securities and Exchange Commission. The firm owned 5,359 shares of the company’s stock after selling 808 shares during the period. TBH Global Asset Management LLC’s holdings in HCA Healthcare were worth $1,451,000 at the end of the most recent quarter.

Several other institutional investors and hedge funds have also recently bought and sold shares of HCA. Norges Bank acquired a new position in shares of HCA Healthcare during the fourth quarter worth about $694,985,000. Kinetic Partners Management LP acquired a new position in shares of HCA Healthcare during the third quarter worth about $50,524,000. EP Wealth Advisors LLC grew its position in shares of HCA Healthcare by 501.8% during the third quarter. EP Wealth Advisors LLC now owns 208,965 shares of the company’s stock worth $51,401,000 after buying an additional 174,240 shares in the last quarter. Retirement Systems of Alabama boosted its holdings in HCA Healthcare by 350.0% in the fourth quarter. Retirement Systems of Alabama now owns 204,812 shares of the company’s stock valued at $55,439,000 after purchasing an additional 159,303 shares in the last quarter. Finally, Canada Pension Plan Investment Board boosted its holdings in HCA Healthcare by 51.6% in the third quarter. Canada Pension Plan Investment Board now owns 355,730 shares of the company’s stock valued at $87,502,000 after purchasing an additional 121,100 shares in the last quarter. 62.73% of the stock is currently owned by hedge funds and other institutional investors.

Wall Street Analyst Weigh In

HCA has been the subject of a number of research analyst reports. Barclays upped their price target on HCA Healthcare from $356.00 to $367.00 and gave the company an “overweight” rating in a report on Monday, April 29th. Deutsche Bank Aktiengesellschaft boosted their price objective on HCA Healthcare from $330.00 to $359.00 and gave the company a “buy” rating in a research note on Friday, April 12th. Wells Fargo & Company boosted their price objective on HCA Healthcare from $303.00 to $315.00 and gave the company an “equal weight” rating in a research note on Thursday, March 28th. Raymond James boosted their price objective on HCA Healthcare from $300.00 to $330.00 and gave the company an “outperform” rating in a research note on Wednesday, January 31st. Finally, Oppenheimer upped their price target on HCA Healthcare from $330.00 to $345.00 and gave the stock an “outperform” rating in a research note on Monday, April 29th. Four research analysts have rated the stock with a hold rating, twelve have assigned a buy rating and one has issued a strong buy rating to the company. Based on data from MarketBeat, the company presently has an average rating of “Moderate Buy” and a consensus target price of $317.00.

Read Our Latest Analysis on HCA

HCA Healthcare Price Performance

Shares of HCA traded up $3.38 during trading hours on Friday, reaching $318.70. 763,650 shares of the company traded hands, compared to its average volume of 1,069,011. The company has a quick ratio of 1.02, a current ratio of 1.16 and a debt-to-equity ratio of 29.26. The stock has a market capitalization of $83.47 billion, a PE ratio of 15.72, a price-to-earnings-growth ratio of 1.48 and a beta of 1.66. HCA Healthcare, Inc. has a fifty-two week low of $215.96 and a fifty-two week high of $335.83. The stock has a fifty day simple moving average of $319.10 and a 200 day simple moving average of $304.97.

HCA Healthcare (NYSE:HCAGet Free Report) last posted its quarterly earnings data on Friday, April 26th. The company reported $5.36 EPS for the quarter, beating analysts’ consensus estimates of $5.01 by $0.35. The business had revenue of $17.34 billion for the quarter, compared to analyst estimates of $16.81 billion. HCA Healthcare had a return on equity of 674.49% and a net margin of 8.20%. The business’s revenue for the quarter was up 11.2% compared to the same quarter last year. During the same quarter last year, the company earned $4.93 earnings per share. As a group, research analysts predict that HCA Healthcare, Inc. will post 20.84 EPS for the current fiscal year.

HCA Healthcare Dividend Announcement

The firm also recently declared a quarterly dividend, which will be paid on Friday, June 28th. Shareholders of record on Friday, June 14th will be issued a $0.66 dividend. This represents a $2.64 annualized dividend and a yield of 0.83%. The ex-dividend date is Friday, June 14th. HCA Healthcare’s dividend payout ratio (DPR) is 13.16%.

HCA Healthcare declared that its Board of Directors has approved a share buyback program on Tuesday, January 30th that authorizes the company to buyback $6.00 billion in shares. This buyback authorization authorizes the company to repurchase up to 7.4% of its stock through open market purchases. Stock buyback programs are generally an indication that the company’s board of directors believes its shares are undervalued.

Insider Buying and Selling at HCA Healthcare

In other news, EVP Michael S. Cuffe sold 1,600 shares of HCA Healthcare stock in a transaction dated Monday, May 6th. The stock was sold at an average price of $309.00, for a total value of $494,400.00. Following the transaction, the executive vice president now directly owns 34,124 shares of the company’s stock, valued at approximately $10,544,316. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is accessible through the SEC website. In other HCA Healthcare news, SVP Kathryn A. Torres sold 973 shares of HCA Healthcare stock in a transaction that occurred on Thursday, May 2nd. The stock was sold at an average price of $312.00, for a total transaction of $303,576.00. Following the sale, the senior vice president now directly owns 22,365 shares in the company, valued at approximately $6,977,880. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is available through the SEC website. Also, EVP Michael S. Cuffe sold 1,600 shares of HCA Healthcare stock in a transaction that occurred on Monday, May 6th. The stock was sold at an average price of $309.00, for a total value of $494,400.00. Following the sale, the executive vice president now owns 34,124 shares in the company, valued at $10,544,316. The disclosure for this sale can be found here. Insiders sold 13,617 shares of company stock worth $4,321,986 in the last 90 days. 1.60% of the stock is owned by company insiders.

About HCA Healthcare

(Free Report)

HCA Healthcare, Inc, through its subsidiaries, owns and operates hospitals and related healthcare entities in the United States. It operates general and acute care hospitals that offers medical and surgical services, including inpatient care, intensive care, cardiac care, diagnostic, and emergency services; and outpatient services, such as outpatient surgery, laboratory, radiology, respiratory therapy, cardiology, and physical therapy.

Recommended Stories

Institutional Ownership by Quarter for HCA Healthcare (NYSE:HCA)

Receive News & Ratings for HCA Healthcare Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for HCA Healthcare and related companies with MarketBeat.com's FREE daily email newsletter.